283 related articles for article (PubMed ID: 16246466)
1. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
[TBL] [Abstract][Full Text] [Related]
2. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.
van der Maaden K; Varypataki EM; Romeijn S; Ossendorp F; Jiskoot W; Bouwstra J
Eur J Pharm Biopharm; 2014 Oct; 88(2):310-5. PubMed ID: 24820032
[TBL] [Abstract][Full Text] [Related]
3. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
Naito S; Ito Y; Kiyohara T; Kataoka M; Ochiai M; Takada K
Vaccine; 2012 Feb; 30(6):1191-7. PubMed ID: 22172508
[TBL] [Abstract][Full Text] [Related]
4. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.
Matriano JA; Cormier M; Johnson J; Young WA; Buttery M; Nyam K; Daddona PE
Pharm Res; 2002 Jan; 19(1):63-70. PubMed ID: 11837701
[TBL] [Abstract][Full Text] [Related]
5. Parameter optimization toward optimal microneedle-based dermal vaccination.
van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
[TBL] [Abstract][Full Text] [Related]
6. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of desmopressin using a coated microneedle array patch system.
Cormier M; Johnson B; Ameri M; Nyam K; Libiran L; Zhang DD; Daddona P
J Control Release; 2004 Jul; 97(3):503-11. PubMed ID: 15212882
[TBL] [Abstract][Full Text] [Related]
8. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
9. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
10. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
11. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
12. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
Chen MC; Huang SF; Lai KY; Ling MH
Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
[TBL] [Abstract][Full Text] [Related]
13. Mass producible and biocompatible microneedle patch and functional verification of its usefulness for transdermal drug delivery.
Jin CY; Han MH; Lee SS; Choi YH
Biomed Microdevices; 2009 Dec; 11(6):1195-203. PubMed ID: 19609679
[TBL] [Abstract][Full Text] [Related]
14. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
15. Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery.
Oh YJ; Cha HR; Hwang SJ; Kim DS; Choi YJ; Kim YS; Shin YR; Nguyen TT; Choi SO; Lee JM; Park JH
Drug Deliv Transl Res; 2021 Aug; 11(4):1390-1400. PubMed ID: 33759112
[TBL] [Abstract][Full Text] [Related]
16. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.
Kumar A; Li X; Sandoval MA; Rodriguez BL; Sloat BR; Cui Z
Int J Nanomedicine; 2011; 6():1253-64. PubMed ID: 21753877
[TBL] [Abstract][Full Text] [Related]
17. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
Li G; Badkar A; Nema S; Kolli CS; Banga AK
Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of Skin Permeation and Skin Immunization of Ovalbumin Antigen via Microneedles.
Pamornpathomkul B; Rojanarata T; Opanasopit P; Ngawhirunpat T
AAPS PharmSciTech; 2017 Oct; 18(7):2418-2426. PubMed ID: 28160208
[TBL] [Abstract][Full Text] [Related]
19. Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen.
Ruutu MP; Chen X; Joshi O; Kendall MA; Frazer IH
Exp Dermatol; 2011 Jun; 20(6):534-6. PubMed ID: 21457356
[TBL] [Abstract][Full Text] [Related]
20. A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin.
Pamornpathomkul B; Wongkajornsilp A; Laiwattanapaisal W; Rojanarata T; Opanasopit P; Ngawhirunpat T
Int J Nanomedicine; 2017; 12():885-898. PubMed ID: 28184159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
